Browse studies
Find your next paid study
4 recruiting studies matching your filters
Observational
Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
Estimated
~$10 – $7,500
MD Stem CellsNCT03011541
Phase 3
Randomized, Multicenter, Vehicle-Controlled, Double-Masked Phase 3 Study to Evaluate the Efficacy and Safety of Intranasal Cenegermin (Recombinant Human Nerve Growth Factor [rhNGF]) in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
This is a phase 3, randomized, multicenter, vehicle-controlled, double-masked study to evaluate the efficacy and safety of intranasal cenegermin compared with …
Non-Arteritic Anterior Ischemic Optic Neuropathy
Estimated
~$10 – $7,500
Dompé Farmaceutici S.p.ANCT07453888
Phase 1
A Phase 1 Single Dose Study to Evaluate the Safety and Tolerability of ER-100 in Optic Neuropathies [Open Angle Glaucoma (OAG) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)]
The goal of this clinical trial is to evaluate the safety and tolerability of a single dose of ER-100 in adults with optic nerve conditions, specifically Open …
Open Angle Glaucoma (OAG)NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)
Estimated
~$10 – $8,750
Life Biosciences Inc.NCT07290244
Observational
New Non-invasive Modalities for Assessing Retinal Structure and Function:Preliminary Investigation
This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects …
Ischemic Optic NeuropathyBranch Retinal Artery OcclusionHemianopia+2 more
Estimated
~$10 – $7,500
Randy KardonNCT03475173